-
Interim NADIM ADJUVANT Data Suggest Adjuvant Chemo-IO May Reduce Recurrence Risk in Patients Following Complete Resection
-
Final FLAURA2 OS Data Show Osimertinib Plus Chemo Offers Benefit Compared with Monotherapy
-
Potential Impact of GLP1-RAs on TKI-induced Weight Gain in Patients with NSCLC
-
No “Known” Risk Factors: The Health Consequences of Radiation Therapy
-
Discussion Covered Updates, Strategies, and Controversies in Lung Cancer Staging
-
No PFS, OS Benefit Seen in Final Results from PACIFIC-2
-
WCLC Attendees Hear Preview of Proposed Changes for the 9th Edition of the TNM Staging Classification for Thoracic Cancers
-
Treatment of Immunotherapy-Related Dermatologic Toxicities: An Interview with Dr. Mario Lacouture
-
A Holistic Approach to Patient Care
Patient Advocacy
-
Management of Long-Term Immune-Related Toxicities Needed in NSCLC
While checkpoint inhibitors have improved the outlook for patients with advanced NSCLC, more information is needed about the long-term toxicities caused by the drugs and how they should be managed. A retrospective study (MA07.05) shed light not only on the power of PD-1/PD-L1 inhibitors to improve overall survival (OS) in this population but also on…
-
Raising Awareness about Lung Cancer Screening among Minorities, People Who Smoke
Minorities are at significantly higher risk for developing lung cancer than whites, even with the same smoking history. In an attempt to, in part, address this disparity, the U.S. Preventive Services Task Force (USPSTF) proposed more inclusive screening guidelines that lowered the age and smoking history for candidates to qualify for screening.1 Presentation MA05.10, “Performance…
-
Lung Cancer Screening for Women: Understanding the Risks and the Benefits
Although science has proven that both men and women significantly benefit from lung cancer screening by low-dose CT, the NELSON study showed that women benefit substantially more than men.1 However, one of the reasons lung cancer screening is not recommended for everyone is due to the potential harm caused by the radiation exposure from low-dose…
-
Program Trains Patient Research Advocates to be STARS
What does it take to become a star in any setting? Passion, knowledge, and drive. When it comes to understanding the science of lung cancer, sometimes the experts are the patients themselves. The IASLC is looking for patients and caregivers who want to learn about lung cancer science and research, as well as develop their…
-
Enhancing Your WCLC Experience with Twitter
Even those who are unfamiliar with social media platforms can find Twitter to be an easy way to discuss research and collaborate with colleagues. If you do not already have a Twitter account, you should consider setting one up now! During a virtual conference, Twitter is the best possible replacement for the hallway conversations that…
-
FDA’s Project Patient Voice Launched to Provide Data on PROs
In 2020 the U.S. Food and Drug Administration (FDA) launched Project Patient Voice, an online platform for patients and caregivers along with their health care providers to look at patient-reported symptom data from cancer clinical trials. This new website, how it functions, and how it might be improved was discussed in July at the FDA-ASCO…
-
A New Year’s Resolution to Promote the Use of Patient-Sensitive Language
In 2021, people living with lung cancer and their caregivers will likely be attending virtual oncology conferences such as the 2020 WCLC and making deep dives into research in record numbers. Due to improvements in lung cancer diagnosis and treatment, more patients with lung cancer are living longer and better, thus becoming increasingly involved in…